Intervention:   idarubicin          

    Access protocols via the Procedure column.
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Wiltshire4 52441 immune cell quantification idarubicin B cells, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 52447 immune cell quantification idarubicin T cells, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 52453 immune cell quantification idarubicin monocytes, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    All boxes